Phanera sirindhorniae (formerly known as Bauhinia sirindhorniae) is a Thai medicinal plant with reported traditional use for the treatment of inflammation; however, its comprehensive phytochemical, biological, and formulation potential remains underexplored. This study aimed to evaluate the phytochemical composition, antioxidant, anti-inflammatory, and antimicrobial activities of extracts from the flower (BSFE), stem (BSSE), and leaf (BSLE), and to develop a BSLE-loaded hydrogel sheet for topical application. Among the extracts, BSSE exhibited the highest total phenolic content (503.71 ± 7.56 mg GAE/g) and total flavonoid content (4778.67 ± 255.47 mg EGCG/g), along with strong antioxidant activity, as demonstrated by DPPH (IC50 = 17.05 µg/mL) and FRAP assays. BSLE showed superior anti-inflammatory activity by significantly suppressing nitric oxide and pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) in LPS-stimulated RAW264.7 macrophages, whereas BSSE displayed moderate effects. In antimicrobial evaluation, BSSE exhibited the strongest activity among the extracts, particularly against Escherichia coli and Staphylococcus species, although its potency remained lower than that of standard antibiotics. HPLC analysis identified 3,4-dihydroxybenzoic acid and luteolin as characteristic anti-inflammatory markers in BSLE. Based on its promising anti-inflammatory activity, BSLE was incorporated into hydrogel sheets (BSLE-F1 and BSLE-F2) using HPMC/PVA matrices with varying PEG 600 content. Both formulations demonstrated suitable physicochemical properties and skin-compatible pH. BSLE-F2 showed improved water retention and dimensional stability, whereas BSLE-F1 exhibited superior peelability, swelling capacity, and tensile strength. In conclusion, BSLE-F1 demonstrated a more favorable balance of mechanical and functional properties, suggesting its suitability as a topical anti-inflammatory hydrogel sheet. This study highlights the potential of P. sirindhorniae extracts for developing multifunctional, natural-based topical delivery systems.

Background/Objectives: Gamma-oryzanol (ORZ), a bioactive compound extracted from rice bran oil, has health-promoting properties but limited therapeutic use due to poor stability and bioavailability. This study aimed to synthesize gamma-oryzanol-encapsulated nanoparticles (ORZ-NPs) and investigate their anti-inflammatory effects in lipopolysaccharide-stimulated RAW 264.7 macrophages. Methods: ORZ-NPs were synthesized via nanoprecipitation and characterized by dynamic light scattering and transmission electron microscopy. ORZ content was assessed using high performance liquid chromatography. In vitro release was determined using a dialysis method. Inducible nitric oxide synthase (iNOS) was assessed by Western blotting, nitric oxide (NO) by Griess assay, and tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) by enzyme-linked immunosorbent assay. Results: ORZ-NPs exhibited spherical morphology with a mean particle size of 93.320 ± 2.027 nm, polydispersity index 0.149 ± 0.025, and zeta potential -22.400 ± 0.252 mV. ORZ remained stable for 90 days. In vitro release reached 70% at 24 h in PBS (pH 7.4). At 50 μg mL-1, ORZ-NPs significantly decreased iNOS and NO production (approximately 65% of control, p < 0.01), without affecting TNF-α or IL-6. Conclusions: ORZ-NPs demonstrate selective anti-inflammatory activities by suppressing iNOS and NO production while pro-inflammatory cytokines remain unaffected. These findings suggest a partial modulatory effect on the inflammatory signaling pathway.

Quercetin, a plant-derived flavonoid with potent antioxidant and anti-inflammatory properties, is limited for topical use by its poor aqueous solubility, low bioavailability, and chemical instability. This research developed and validated a formulation-driven strategy to stabilize quercetin by encapsulating it in lipid nanoparticles (QLNs) and embedding these in a Carbopol hydrogel, providing comprehensive physicochemical and functional stability data. A fully validated HPLC-PDA assay was used to quantify quercetin in the nanoparticle-hydrogel matrix. In vitro bioactivity testing showed notable antioxidant activity (DPPH IC50 6.84 ± 0.12 µg/mL; ABTS IC50 4.04 ± 0.08 µg/mL; FRAP 301.46 ± 3.68 µg/mL) and an anti-inflammatory effect in LPS-stimulated RAW264.7 macrophages (1 µM quercetin reduced NO from 50.72 ± 2.00 µM to 41.57 ± 3.12 µM, p < 0.05). Forced degradation mapping across acidic, basic, oxidative, and photolytic conditions defined degradation pathways (complete loss in 1 N NaOH at 24 h; greater retention in 1 N HCl, 3% H2O2, and UV-254). QLN-hydrogel formulations remained physically and chemically stable through heating-cooling cycles and 180-day storage at multiple temperatures, retaining >90% quercetin and preserving antioxidant and anti-inflammatory activities (<10% reduction). These results establish a robust, application-ready approach for maintaining quercetin's chemical integrity and bioactivity in topical formulations.

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two main neurodegenerative diseases and cause disability and death in patients worldwide. Neurodegeneration is characterized by a progressive loss of neuronal function and structure, causing enormous impairment in cognitive-motor function. Magnolol and honokiol are isomeric biphenyl neolignans and have exhibited neuroprotective activity in previous studies. Hence, we assessed and compared honokiol, magnolol, and mixtures of honokiol and magnolol in honokiol/magnolol molar ratios of 1:3, 1:1, and 3:1 in terms of their neurotoxicity, using the cell counting kit-8 (CCK-8) assay, and of their neuroprotective effect on intracellular reactive oxygen species (iROS) against amyloid-beta (Aβ)- and 1-methyl-4-phenylpyridinium ion (MPP+)-induced neurotoxicity in SH-SY5Y cells, using the 2',7'-dichlorodihydrofluorescein diacetate (H2DCF-DA) assay. The results showed that honokiol (H) and magnolol (M) at 0.1 μM and the mixtures of honokiol and magnolol in H/M ratios of 1:3, 1:1, and 3:1 at 0.0001 μM exhibited a significant neuroprotective effect of reducing iROS in SH-SY5Y cells where neurotoxicity was induced by Aβ- and MPP+ (p-value with respect to Aβ-treated cells < 0.005 and p-value with respect to MPP+-treated cells < 0.0001). Moreover, magnolol and honokiol possess antioxidant properties according to computational molecular analysis with Highest Occupied Molecular Orbital (HOMO)- Lowest Unoccupied Molecular Orbital (LUMO) prediction, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and Ferric Reducing Antioxidant Power (FRAP) assays. The mixtures of honokiol and magnolol exerted synergistic neuroprotective ability at all ratios while showing better antioxidation ability than that of pure magnolol alone but comparable to that of pure honokiol alone. Drug-likeness, Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) prediction, and toxicity profiles showed that both compounds are promising neuroprotective agents and that one of the possible targeting mechanisms is the ROS-mediated oxidative stress pathway. Additional neuronal cell lines and in vivo models are required to determine similar effects or other protective mechanisms involving the neuroprotective ability of honokiol and magnolol.

Abscess formation is commonly precipitated by bacterial infection. This study delineates the phytochemical composition and evaluates the antioxidant, antibacterial, and anti-biofilm activities of a Thai traditional anti-abscess herbal formulation comprising Curcuma zedoaria, Vitex trifolia, and Azadirachta indica. Validated high-performance liquid chromatography-photodiode array detection (HPLC-PDA) analysis of the ethanolic extract identified curcumin, demethoxycurcumin, bisdemethoxycurcumin, and vitexicarpin as principal constituents. Total phenolic and flavonoid contents were 32.08 ± 2.54 mg GAE/g and 17.52 ± 1.28 mg QE/g dry weight, respectively. Antioxidant assessment by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay yielded an half maximal inhibitory concentration (IC50) of 53.46 ± 3.24 µg/mL, while reducing power corresponded to 383.97 ± 13.24 µg FeSO4/g dry weight. Molecular orbital analysis revealed a highest occupied molecular orbital and lowest unoccupied molecular orbital (HOMO-LUMO) gap for vitexicarpin (ΔE = 9.7710 eV), indicative of greater radical-scavenging potential relative to curcuminoids. Antibacterial assays demonstrated selective activity against Staphylococcus epidermidis (inhibition zone 1.48 ± 0.16 cm), with no observed inhibition of Staphylococcus aureus or Streptococcus pyogenes. Curcumin exhibited the highest activity against S. epidermidis (minimum inhibitory concentration (MIC) 62.5 µg/mL; minimal bactericidal concentration minimal bactericidal concentration (MBC) 125 µg/mL). Molecular docking showed curcumin binding to the teicoplanin-associated transcriptional regulator (TcaR) with a binding energy of -8.00 kcal/mol, comparable to methicillin (-8.16 kcal/mol), suggesting a potential mechanism for modulation of biofilm-associated regulatory pathways. Collectively, these findings indicate that the formulation has measurable antioxidant activity and targeted antibacterial efficacy against S. epidermidis, which may contribute to attenuation of abscess progression via interference with biofilm regulation.

Combining plant-derived bioactives could produce effective anti-inflammatory interventions for myofascial inflammation. This study evaluated in vitro synergy and computational mechanisms of curcumin-evodiamine activity against TNF-α, IL-1β, iNOS and COX-2, with frontier molecular orbital analysis to inform putative mechanisms. Evodiamine and curcumin were identified/quantified by HPLC-PDA and LC-MS (λmax 226 nm and 426 nm; RT 8.61 and 9.53 min; [M-H]-m/z 302.2 and 367.2). Purities were 98.08 ± 1.92% and 98.04 ± 1.86%. Noncytotoxic concentrations in RAW264.7 cells were determined, then LPS-stimulated cells were treated with evodiamine (0.01 µM), curcumin (0.01 µM) and a 1:1 mixture (0.001 µM). Molecular docking against TNF-α, IL-1β, iNOS and COX-2 and HOMO-LUMO calculations were performed. Curcumin and the combination significantly reduced TNF-α and NO; curcumin and the combination reduced IL-1β, whereas evodiamine alone showed limited effects. Docking predicted stronger binding for curcumin and evodiamine than ibuprofen across targets (e.g., curcumin ΔG -10.18 kcal·mol-1 for TNF-α; evodiamine ΔG -10.02 kcal·mol-1 for COX-2). Frontier orbital energies indicated differing electronic profiles (ibuprofen ΔE 8.62 eV; evodiamine 9.65 eV; curcumin 9.89 eV), suggesting complementary reactivity. The curcumin-evodiamine combination exhibits in vitro anti-inflammatory activity with supportive docking and orbital data, providing mechanistic rationale for further development.

This study explored the extraction of genistein-7-O-[α-rhamnopyranosyl-(1→6)]-β-glucopyranoside (GTG) from Derris scandens using an aqueous-ethanol solvent system, aiming to optimize yield and antioxidant activity. Hansen solubility parameters (HSP) were employed to determine the optimal solvent composition, with the highest GTG yield (6.83 ± 0.06 mg/g dried weight) obtained from 50% ethanol—correlating well with HSP predictions. Ultrasonic extraction was most effective with solvents having a dielectric constant between 50 and 60. The antioxidant potential of isolated GTG was evaluated using the DPPH assay, which yielded an IC50 of 87.86 ± 1.85 μM, and the FRAP assay, with a value of 34.23 ± 2.75 mg FeSO4 equivalents. Molecular orbital analysis revealed HOMO and LUMO energy gaps (ΔE = 10.6715 eV) similar to known antioxidants such as gallic acid, ascorbic acid, Trolox, and quercetin. These findings demonstrate that HSP effectively guided solvent selection for ultrasound-assisted extraction of GTG. The antioxidant activity is attributed to GTG’s capacity to donate electrons and stabilize radicals via extended charge delocalization within the aglycone structure, confirming its potential as a natural antioxidant agent.

This study investigates the impact of corona discharge plasma treatments on the phytochemical composition, antioxidant activity, and neuroprotective potential of Eclipta prostrata Linn. (Kameng) grown from plasma-treated seeds. Plasma treatments were applied at varying voltages (+/- 15, +/- 22.5, and +/- 30 kV) and durations (30, 60, and 90 seconds) under both positive and negative polarities. Positive polarity treatments, particularly at +30 kV for 90 seconds, significantly enhanced the levels of key bioactive compounds, including wedelolactone (6.75 +/- 0.01 mg/g), total phenolic content (73.23 +/- 0.87 mg GAE/g), and total flavonoid content (120.39 +/- 1.47 mg QE/g). DPPH antioxidant activity assay, measured through IC50 values, showed remarkable improvement, with the lowest IC50 recorded at 2.76 +/- 0.01 mu g/mL. Positive polarity also optimized germination rates (up to 77.67%) and promoted plant growth with enhanced root and straw lengths. Plasma-treated extracts demonstrated significant neuroprotective effects against A beta 42 and MPP+-induced toxicity in SH-SY5Y cells, correlating with elevated wedelolactone, phenolic acid and flavonoid levels. The findings reveal the potential of plasma technology as a non-thermal, eco-friendly method to enhance the bioactive properties and therapeutic applications of E. prostrata . This study provides valuable insights into the scalability and broader implications of plasma treatments for agricultural and pharmaceutical industries.

Cancer remains a significant global health challenge, necessitating novel therapeutic interventions. Clerodendrum chinense leaf extract (CCL) has gained interest for its potential anticancer properties due to its bioactive composition. This study aims to evaluate the cytotoxic effects of CCL against MCF-7 breast cancer and HeLa cervical cancer cells and elucidate its mechanisms of action. High-performance liquid chromatography identified verbascoside, isoverbascoside, and hispidulin as the major bioactive compounds. CCL exhibited time- and dose-dependent cytotoxicity, with MCF-7 cells showing greater sensitivity (IC50 = 126.8 µg/mL, 72 h) than HeLa cells (216.1 µg/mL, 72 h). Flow cytometry confirmed apoptotic induction, with late apoptosis increasing at moderate concentrations (16.03–23.55%) and necrosis prevailing at higher doses (50.80–63.68%). Reactive oxygen species generation was significantly elevated in MCF-7 (70.2%) and HeLa (60.4%) cells at 250 µg/mL. CCL effectively suppressed colony formation and cell migration in a dose-dependent manner. Molecular docking studies demonstrated that apoptosis induction of CCL bioactive compounds may mediate through the pro-apoptotic BCL2 associated X, apoptosis regulator (BAX) regulator. These findings highlight the potential of CCL as a natural anticancer agent with multiple mechanisms, including reactive oxygen species (ROS)-induced apoptosis, BAX activation, and inhibition of proliferation and metastasis.

Non-small cell lung cancer (NSCLC) is a challenging disease, with the epidermal growth factor receptor (EGFR) being a key target for new, effective treatments crucial for the signaling pathways regulating cancer cell survival. Targeting EGFR-mediated signaling offers promising strategies to improve NSCLC therapies, particularly in overcoming resistance in EGFR-mutant lung cancer. In this study, we investigated the anticancer effects of panduratin A, a naturally occurring flavonoid from Boesenbergia rotunda, on human NSCLC cell lines expressing both wild-type EGFR (A549) and mutant EGFR (H1975) using in vitro experiments and molecular docking approaches. Cytotoxicity screening revealed that panduratin A exhibits potent effects on both A549 (IC50 of 6.03 ± 0.21 µg/mL) and H1975 (IC50 of 5.58 ± 0.15 µg/mL) cell lines while demonstrating low toxicity to normal MRC5 lung cells (12.96 ± 0.36 µg/mL). Furthermore, western blotting and flow cytometric analyses indicated that panduratin A induces apoptosis by inhibiting p-EGFR and its downstream effectors, p-STAT3 and p-Akt, in lung cancer cells. Additionally, the docking study showed lower binding energy between panduratin A and the target proteins, comparable to that of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs). The ADMET prediction also highlighted panduratin A’s exceptional drug-like properties. This study concludes that panduratin A shows significant promise as an anti-lung cancer candidate for NSCLC, offering an economical and effective strategy.

Alzheimer’s disease is characterized by the degeneration of cholinergic neurons, which is primarily driven by the acetylcholinesterase (AChE) enzyme and oxidative stress. This study investigated the therapeutic potential of the cannabis-containing herbal remedy Suk-Saiyasna in alleviating amyloid β42 (Aβ42)-induced cytotoxicity in SH-SY5Y cells. The DPPH radical-scavenging activity and inhibitory effects on AChE were evaluated in vitro. The AChE inhibitory potential of 167 ligands, including cannabinoids, flavonoids, terpenoids, and alkaloids derived from Suk-Saiyasna, was assessed using ADMET analysis and molecular docking techniques. The results demonstrated that the Suk-Saiyasna extract exhibited a DPPH radical scavenging effect with an IC50 value of 27.40 ± 1.15 µg/mL and notable AChE inhibitory activity with an IC50 of 1.25 ± 0.35 mg/mL. Importantly, at a concentration of 1 µg/mL, the extract significantly protected cells from Aβ42-induced stress compared to controls. Docking studies revealed that delta-9-tetrahydrocannabinol (Δ9-THC), mesuaferrone B, piperine, β-sitosterol, and chlorogenic acid exhibited substantial binding affinities to AChE, surpassing reference drugs like galantamine and rivastigmine. Furthermore, in silico ADMET predictions indicated that Δ9-THC and piperine possessed favorable pharmacokinetic profiles, including solubility, absorption, and blood–brain barrier permeability, with no neurotoxicity or carcinogenicity associated with Δ9-THC.

Outer membrane protein A (OmpA) of Acinetobacter baumannii as the major virulence factor coupled with efflux pump systems mediates resistance to various antibiotics. Silver nanoparticles (AgNPs) are explored as novel multi-functional therapeutic agents that would effectively suppress multidrug-resistant bacterial strains and mitigate inflammatory responses, resulting from bacterial infections. Aqueous leaf extract of E. camaldulensis was profiled and used as a reducing and capping agent during the biosynthesis of AgNPs. Moreover, chromatography profiled data of extract were docked to understand the in silico therapeutic potential for antibacterial, antioxidant, and anti-inflammatory activity. Furthermore, synthesized AgNPs were investigated as a novel approach to reduce OmpA of A. baumannii. Liquid chromatography coupled with a mass spectrophotometer (LC–MS) indicated that E. camaldulensis aqueous leaf extract is a plethora of phenolic bioactive reservoirs. Molecular docking results revealed that the major phytochemicals identified from Eucalyptus camaldulensis exhibited superior binding modes, indicating favorable orientation and interactions within the active site and stronger binding affinities (more negative docking scores) to the outer membrane protein A (OmpA) of Acinetobacter baumannii (PDB ID: 5F19), compared to the standard antibiotic ciprofloxacin. The synthesized AgNPs demonstrated surface plasmon resonance peak at 411 nm, and the size of nanoparticles (NPs) was in the range of 16.67 to 24.85 nm with insignificant change in vibration infra-red intensity. Antibacterial activity of AgNPs showed that minimum inhibitory concentration ranged between 2.70 and 5.40 µg/mL against tested bacterial isolates. Moreover, AgNPs considerably reduced A. baumannii OmpA expression by up to 70

This study investigates the impact of corona discharge plasma treatments on the phytochemical composition, antioxidant activity, and neuroprotective potential of Eclipta prostrata Linn. (Kameng) grown from plasma-treated seeds. Plasma treatments were applied at varying voltages (±15, ±22.5, and ±30 kV) and durations (30, 60, and 90 seconds) under both positive and negative polarities. Positive polarity treatments, particularly at +30 kV for 90 seconds, significantly enhanced the levels of key bioactive compounds, including wedelolactone (6.751 ± 0.004 mg/g), total phenolic content (73.229 ± 0.874 mg GAE/g), and total flavonoid content (120.388 ± 1.472 mg QE/g). DPPH antioxidant activity assay, measured through IC₅₀ values, showed remarkable improvement, with the lowest IC₅₀ recorded at 2.755 ± 0.004 μg/mL. Positive polarity also optimized germination rates (up to 77%) and promoted plant growth with enhanced root and straw lengths. Plasma-treated extracts demonstrated significant neuroprotective effects against Aβ42 and MPP+-induced toxicity in SH-SY5Y cells, correlating with elevated wedelolactone, phenolic acid and flavonoid levels. The findings reveal the potential of plasma technology as a non-thermal, eco-friendly method to enhance the bioactive properties and therapeutic applications of E. prostrata. This study provides valuable insights into the scalability and broader implications of plasma treatments for agricultural and pharmaceutical industries.

This study explores the chemical composition and synergistic anti-fungal properties of essential oils from the aerial parts of Satavari (Asparagus racemosus Willd.), Dill (Anethum graveolens L.), and lemongrass (Cymbopogon citratus Stapf), along with the peels of Lime (Citrus aurantifolia (Christm.)) and Kaffir lime (Citrus hystrix DC), as well as the leaves of Citrus hystrix DC, against Malassezia furfur, a yeast linked to dandruff and seborrheic dermatitis. Gas chromatography-mass spectrometry (GC-MS) identified key volatile compounds within these oils. In vitro anti-fungal assays evaluated their efficacy individually and in combinations using checkerboard dilution techniques to assess synergy. Results indicated significant antifungal activity, with lemongrass exhibiting the strongest effect (MIC of 0.125% v/v). Notably, a 1:1 combination of lemongrass and kaffir lime essential oils showed synergism, reducing the MIC to 0.0625% v/v. The antifungal activity was primarily attributed to citral and citronellal, with MICs of 0.03125% v/v and 0.125% v/v, respectively. Molecular orbital analysis revealed that the higher energy levels of the lowest unoccupied molecular orbitals (LUMOs) in citral correlate with greater antifungal efficacy, likely due to its enhanced electrophilicity, facilitating nucleophilic interactions with M. furfur’s cellular components. These findings highlight potential applications of essential oil combinations in antifungal therapies.

The Pet-Sang-Kard mixed herbal remedy (PSKMHR) is a traditional Thai medicinal formulation used as an herbal supplement for the treatment of hemorrhoids. This remedy consists of four specific herbal ingredients in the following proportions: 50 parts Cissus quadrangularis L. stems, 15 parts Eclipta prostrata L. aerial parts, 10 parts Rheum sp. rhizome, and 10 parts Boesenbergia rotunda (L.) Mansf. rhizome. This study presents the development, validation, and application of a high-performance liquid chromatography with photodiode array detection (HPLC-PDA) method designed for the simultaneous quantification of 13 key bioactive compounds, including rhaponticin, rhapontigenin, quercitrin, wedelolactone, aloe-emodin, rhein, emodin, chrysophanol, physcion, alpinetin, pinocembrin, pinostrobin, and panduratin A, present in the 70% ethanolic extract of PSKMHR. Method validation was conducted in accordance with Association of Official Analytical Collaboration (AOAC) international guidelines, evaluating parameters such as the specificity, linearity, accuracy, precision, and limit of detection. The results demonstrated exceptional linearity (R > 0.9999), high precision (% RSD < 2), and recovery rates within acceptable limits (98-102%) for all analytes. This developed method was successfully applied to quantify the 13 target compounds in the crude extracts of PSKMHR formulated from 10 market raw material samples, providing a robust analytical framework for quality control of this herbal remedy.

Yataprasen (YTPS) remedy ethanolic spray, one of the National Thai Traditional Medicine Formulary, is extensively employed in Thai traditional healthcare to manage musculoskeletal pain and inflammation. Despite its widespread use, the quality and stability of the YTPS formulation, critical to its efficacy, safety, and patient adherence, have not been comprehensively studied. This research developed and optimized a film-forming spray (FFS) formulation of YTPS ethanolic extract and conducted a 6-month stability evaluation. The FFS shares similarities with gel formulations, particularly in its ability to form a cohesive, semi-solid film upon application, enhancing localized drug delivery and prolonged contact time. Key physicochemical properties, including density (0.8450–0.9086 g/cm3), pH (4.72–4.95), spray angle (55.58–60.10°), evaporation time (1.04–1.27 min), and theoretical film thickness (7.72–13.97 µm), were analyzed across varying storage conditions. Active components β-amyrin and stigmasterol demonstrated retention rates of 96.78% and 68.22%, respectively, under refrigerated conditions, with degradation rates accelerating at higher temperatures. Significant variations in density, spray angle, film thickness, and stigmasterol concentration were observed. Additionally, the RP-HPLC method was validated for the accurate and precise quantification of the bioactive compounds such as β-amyrin and stigmasterol, demonstrating excellent linearity within a 10–100 µg/mL range for both compounds with excellent linearity R2 > 0.999. The results confirmed that YTPS-FFS exhibits good stability and that the validated HPLC method is reliable for routine quality control. These findings supported the potential of YTPS-FFS formulation as a standardized and effective dosage form for managing musculoskeletal conditions, advancing its role in modernized traditional medicine.

This research focused on the formulation of ciprofloxacin hydrochloride ear drops for the treatment of acute otitis externa, caused by pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa. The study aimed to enhance the solubility of ciprofloxacin at physiological pH and improve its stability during autoclave sterilization by employing polyalcohol vehicle systems composed of deionized water, glycerin, and propylene glycol. Formulations containing 0.33% w/v ciprofloxacin HCl were evaluated for solubility within a pH range of 4.0 to 7.0 and underwent autoclave sterilization to assess their chemical stability and antibacterial efficacy. Following sterilization, the formulations were stored at 25 °C in amber containers for a duration of 180 days. High-performance liquid chromatography (HPLC) was utilized to evaluate chemical stability, while antibacterial activity was determined using the disk diffusion method. The results demonstrated that glycerin and propylene glycol effectively inhibited ciprofloxacin precipitation at physiological pH. The ciprofloxacin content decreased by less than 3.58% while preserving antimicrobial efficacy against S. aureus and P. aeruginosa. Both formulations retained over 90% of their labeled drug content, indicating a minimum shelf life of 180 days under the specified storage conditions.

Background/Objectives: This study aimed to investigate the antioxidant and anti-inflammatory properties of a Hand and Foot Soaking Formulary composed of ten medicinal plants, with curcumin as a major bioactive marker, to provide scientific validation for its traditional use. Methods: The formulation was evaluated for total phenolic and flavonoid contents, with curcumin quantified using HPLC. Antioxidant activity was assessed using DPPH, ABTS, and FRAP assays. Cytotoxicity was evaluated in RAW264.7 cells using the MTT assay. Anti-inflammatory activity was determined by measuring nitric oxide (NO), PGE2, TNF-α, IL-1β, and IL-6 levels in LPS-stimulated RAW264.7 macrophages using ELISA. Results: The Hand and Foot Soaking Formulary exhibited promising antioxidant and anti-inflammatory properties, consistent with its traditional use. Phytochemical analysis confirmed the presence of bioactive compounds, with measurable levels of total phenolics, flavonoids, and significant curcumin content. Antioxidant activity was demonstrated through free radical scavenging and ferric-reducing assays, while cytotoxicity testing in RAW264.7 macrophages indicated low toxicity (IC50 = 48.61 ± 3.80 µg/mL). The formulary significantly reduced LPS-induced nitric oxide, PGE2, TNF-α, IL-1β, and IL-6 production. These effects were comparable to turmeric extract and curcumin, though curcumin displayed higher potency. Conclusions: The Hand and Foot Soaking Formulary demonstrates antioxidant and anti-inflammatory properties in vitro, supporting its traditional use. Its polyherbal composition may offer synergistic effects and holds promise as a safe, natural topical remedy.

This study investigates the impact of the Electrical Breakdown in Liquid-phase (EBL) process on alkaloid transformation in Mitragyna speciose (Kratom) leaves, focusing on the conversion of mitragynine (MG) to 7-hydroxy mitragynine (7-OH-MG) by using advanced oxidation processes (AOPs). A novel reactor has been developed to enhance plasma exposure to Kratom leaf powdered solutions during the EBL process. Two distinct electrical voltage characteristics, half-positive and negative half-waves, have been utilized for the EBL, with an output voltage of 4.57 kV peak at a noload condition and a frequency of 50 Hz. The experimental findings demonstrate a time- dependent enhancement in the transformation process. The highest yield of 7-OH-MG, reaching 2,485 +/- 134 mu g/g of dried Kratom leaves weight, has been attained with the EBL processing generated by positive half-wave voltage after 20 min of EBL exposure. Notably, the EBL processing generated by positive half-wave voltage has outperformed the one generated by negative half-wave voltage by a significant factor of 2.01.

The bioactive flavonoids pinostrobin (PN) and panduratin A (PA) from Boesenbergia rotunda are essential for research and therapeutic applications. This study introduces an innovative method utilizing ultrasound-assisted extraction with n-hexane pre-treatment, followed by one-step centrifugal partition chromatography (CPC) purification. Extraction efficiency was evaluated using ultra high-performance liquid chromatography (UHPLC), and the isolated compounds were characterized through 1H-NMR and liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS), adhering to AOAC validation guidelines. Optimal extraction conditions comprised a particle size of 125 μm, a solid-to-liquid ratio of 1:30 g/mL, and a 10 min extraction time, yielding a crude extract of 6.96 ± 0.07%. Using an n-hexane/MeOH/water (5/3.4/1.6, v/v) solvent system in ascending mode, PN (2.16 mg, 98.78% purity) and PA (0.4 mg, 99.69% purity) were isolated from 67 mg of crude extract within 30 min. This streamlined approach enhances purification efficiency, allowing for faster extraction and higher purity, making it a suitable method for commercial applications.